Michrom Bioresources Revenue and Competitors
Estimated Revenue & Valuation
- Michrom Bioresources's estimated annual revenue is currently $930k per year.
- Michrom Bioresources's estimated revenue per employee is $155,000
Employee Data
- Michrom Bioresources has 6 Employees.
- Michrom Bioresources grew their employee count by 0% last year.
Michrom Bioresources's People
| Name | Title | Email/Phone |
|---|
Michrom Bioresources Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is Michrom Bioresources?
Michrom Bioresources was incorporated in April, 1989 to provide innovative microfluidic products for life science applications. As a pioneer in the field of microscale protein and peptide separations, Michrom has evolved to become a premier supplier of LCMS instruments, accessories and consumables for proteomics researchers around the world. Michrom is a privately held, ISO 9001 certified company that has shown steady growth over the past 20 years, including a spot on the INC 500 list of the fastest growing privately held companies in America. With thousands of customers in biotech, pharmaceutical, clinical, academic and government research labs worldwide, Michrom has developed an excellent reputation as a resource for solutions to complex proteomics LCMS applications
keywords:N/A
N/A
Total Funding
6
Number of Employees
$930k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.2M | 6 | -25% | $2.3M |
#2 | $0.7M | 6 | -62% | N/A |
#3 | $0.4M | 6 | N/A | N/A |
#4 | $0.4M | 6 | N/A | N/A |
#5 | $0.4M | 6 | N/A | N/A |